Global cancer biopsy market is expected to expand in the next five years with an impressive  (CAGR) due to emerging significance of cancer biopsies and tissue sectioning to provide information like oncological molecular profile. The market growth can also be attributed to the increased uses of liquid biopsies that are non-invasive procedure and holds advantage over other methods. Oncology diagnostics is another term for the cancer biopsy and it includes various techniques like skin biopsy, needle biopsy, bone marrow biopsy, endoscopic and surgical biopsies. Technological advancements in these biopsy procedures are anticipated to drive the growth of the global cancer biopsy market in the forecast period, 2022-2026. Moreover, consistent research is ongoing to find the better and easier method for the early diagnosis of the chronic diseases like cancer. The disease is often diagnosed at a later stage when the treatment is no more feasible or is not effective to treat the cancer. The extensive research will boost the growth of the global cancer biopsy market in the next five years until 2026.

The global cancer biopsy market is segmented on the basis of product, type of biopsy, application, end user, competitive landscape, and regional distribution. Based on product the market is divided into instruments, kits and consumables and services. Kits and consumables are anticipated to hold the largest share in the market in the forecast period, owing to its dominant growth to the factors like increased demand of them at various levels of biopsies and robust investment by the market players that already have a set market in the industry. Moreover, patients are also demanding for the efficient, accurate and rapid kits thereby influencing the growth of the market in the forecast period.

Some of the major competitors in the market are Qiagen N.V., Illumina, Inc., ANGLE Plc, Becton, Dickinson and Company, Myriad Genetics Inc., Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lucence Diagnostics Pte. Ltd., GRAIL, Inc., Guardant Health Inc., Exact Sciences Corporation, Freenome Holdings, Inc., among others. Other strategies include forming partnerships among the market players and the research institutions, and launching technologically advanced products and services in the forecast period.

Years considered for this report:

Historical Years: 2016 – 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 – 2026

Objective of the Study:

  • To analyze the historical growth of the market size of global cancer biopsy market from 2016 to 2020.
  • To estimate and forecast the market size of global cancer biopsy market from 2021 to 2026 and growth rate until 2026. 
  • To classify and forecast global cancer biopsy market based on product, type of biopsy, application, end user, regional distribution, and competitive landscape.
  • To identify dominant region or segment in the global cancer biopsy market.
  • To identify drivers and challenges for global cancer biopsy market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global cancer biopsy market.
  • To identify and analyze the profile of leading players operating in global cancer biopsy market.
  • To identify key sustainable strategies adopted by market players in global cancer biopsy market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and service providers across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global cancer biopsy market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, service providers and other stakeholders
  • Distributers and suppliers of cancer biopsy equipment and other stakeholders
  • Organizations, forums, and alliances related to cancer biopsy market   
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global cancer biopsy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Cancer Biopsy Market, By Product:
    • Instruments
    • Kits and Consumables
    • Services
  • Global Cancer Biopsy Market, By Type of Biopsy:
    • Tissue Biopsies
      • Needle
      • Surgical Biopsies
    • Liquid Biopsies
    • Others
  • Global Cancer Biopsy Market, By Application:
    • Breast Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Prostate Cancer
    • Pancreatic Cancer
    • Ovarian Cancer
    • Others
  • Global Cancer Biopsy Market, By End User:
    • Reference Laboratories
    • Hospitals and Physician Laboratories
    • Academic and Research Centers
  • Global Cancer Biopsy Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global cancer biopsy market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Cancer Biopsy Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.     Product Overview

2.     Research Methodology

3.     Impact of COVID-19 on Global Cancer Biopsy Market

4.     Executive Summary

5.     Voice of Customer

6.     Global Cancer Biopsy Market Outlook

6.1.   Market Size & Forecast

6.1.1.      By Value

6.2.   Market Share & Forecast

6.2.1.      By Product (Instruments, Kits and Consumables, Services)

6.2.2.      By Type of Biopsy (Tissue Biopsies (Needle and Surgical Biopsies), Liquid Biopsies, Others)

6.2.3.      By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Others)

6.2.4.      By End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers)

6.2.5.      By Company (2020)

6.2.6.      By Region

6.3.   Product Market Map

7.     Asia-Pacific Cancer Biopsy Market Outlook

7.1.   Market Size & Forecast          

7.1.1.      By Value

7.2.   Market Share & Forecast

7.2.1.      By Product

7.2.2.      By Type of Biopsy

7.2.3.      By Application

7.2.4.      By End User

7.2.5.      By Country

7.3.   Asia-Pacific: Country Analysis

7.3.1.      China Cancer Biopsy Market Outlook

7.3.1.1.           Market Size & Forecast

7.3.1.1.1.                By Value

7.3.1.2.           Market Share & Forecast

7.3.1.2.1.                By Product

7.3.1.2.2.                By Type of Biopsy

7.3.1.2.3.                By Application

7.3.1.2.4.                By End User

7.3.2.      India Cancer Biopsy Market Outlook

7.3.2.1.           Market Size & Forecast

7.3.2.1.1.                By Value

7.3.2.2.           Market Share & Forecast

7.3.2.2.1.                By Product

7.3.2.2.2.                By Type of Biopsy

7.3.2.2.3.                By Application

7.3.2.2.4.                By End User

7.3.3.      Japan Cancer Biopsy Market Outlook

7.3.3.1.           Market Size & Forecast

7.3.3.1.1.                By Value

7.3.3.2.           Market Share & Forecast

7.3.3.2.1.                By Product

7.3.3.2.2.                By Type of Biopsy

7.3.3.2.3.                By Application

7.3.3.2.4.                By End User

7.3.4.      South Korea Cancer Biopsy Market Outlook

7.3.4.1.           Market Size & Forecast

7.3.4.1.1.                By Value

7.3.4.2.           Market Share & Forecast

7.3.4.2.1.                By Product

7.3.4.2.2.                By Type of Biopsy

7.3.4.2.3.                By Application

7.3.4.2.4.                By End User

7.3.5.      Australia Cancer Biopsy Market Outlook

7.3.5.1.           Market Size & Forecast

7.3.5.1.1.                By Value

7.3.5.2.           Market Share & Forecast

7.3.5.2.1.                By Product

7.3.5.2.2.                By Type of Biopsy

7.3.5.2.3.                By Application

7.3.5.2.4.                By End User

8.     Europe Cancer Biopsy Market Outlook

8.1.   Market Size & Forecast          

8.1.1.      By Value

8.2.   Market Share & Forecast

8.2.1.      By Product

8.2.2.      By Type of Biopsy

8.2.3.      By Application

8.2.4.      By End User

8.2.5.      By Country

8.3.   Europe: Country Analysis

8.3.1.      France Cancer Biopsy Market Outlook

8.3.1.1.           Market Size & Forecast

8.3.1.1.1.                By Value

8.3.1.2.           Market Share & Forecast

8.3.1.2.1.                By Product

8.3.1.2.2.                By Type of Biopsy

8.3.1.2.3.                By Application

8.3.1.2.4.                By End User

8.3.2.      Germany Cancer Biopsy Market Outlook

8.3.2.1.           Market Size & Forecast

8.3.2.1.1.                By Value

8.3.2.2.           Market Share & Forecast

8.3.2.2.1.                By Product

8.3.2.2.2.                By Type of Biopsy

8.3.2.2.3.                By Application

8.3.2.2.4.                By End User

8.3.3.      United Kingdom Cancer Biopsy Market Outlook

8.3.3.1.           Market Size & Forecast

8.3.3.1.1.                By Value

8.3.3.2.           Market Share & Forecast

8.3.3.2.1.                By Product

8.3.3.2.2.                By Type of Biopsy

8.3.3.2.3.                By Application

8.3.3.2.4.                By End User

8.3.4.      Italy Cancer Biopsy Market Outlook

8.3.4.1.           Market Size & Forecast

8.3.4.1.1.                By Value

8.3.4.2.           Market Share & Forecast

8.3.4.2.1.                By Product

8.3.4.2.2.                By Type of Biopsy

8.3.4.2.3.                By Application

8.3.4.2.4.                By End User

8.3.5.      Spain Cancer Biopsy Market Outlook

8.3.5.1.           Market Size & Forecast

8.3.5.1.1.                By Value

8.3.5.2.           Market Share & Forecast

8.3.5.2.1.                By Product

8.3.5.2.2.                By Type of Biopsy

8.3.5.2.3.                By Application

8.3.5.2.4.                By End User

9.     North America Cancer Biopsy Market Outlook

9.1.   Market Size & Forecast          

9.1.1.      By Value

9.2.   Market Share & Forecast

9.2.1.      By Product

9.2.2.      By Type of Biopsy

9.2.3.      By Application

9.2.4.      By End User

9.2.5.      By Country

9.3.   North America: Country Analysis

9.3.1.      United States Cancer Biopsy Market Outlook

9.3.1.1.           Market Size & Forecast

9.3.1.1.1.                By Value

9.3.1.2.           Market Share & Forecast

9.3.1.2.1.                By Product

9.3.1.2.2.                By Type of Biopsy

9.3.1.2.3.                By Application

9.3.1.2.4.                By End User

9.3.2.      Mexico Cancer Biopsy Market Outlook

9.3.2.1.           Market Size & Forecast

9.3.2.1.1.                By Value

9.3.2.2.           Market Share & Forecast

9.3.2.2.1.                By Product

9.3.2.2.2.                By Type of Biopsy

9.3.2.2.3.                By Application

9.3.2.2.4.                By End User

9.3.3.      Canada Cancer Biopsy Market Outlook

9.3.3.1.           Market Size & Forecast

9.3.3.1.1.                By Value

9.3.3.2.           Market Share & Forecast

9.3.3.2.1.                By Product

9.3.3.2.2.                By Type of Biopsy

9.3.3.2.3.                By Application

9.3.3.2.4.                By End User

10.  South America Cancer Biopsy Market Outlook

10.1.                 Market Size & Forecast

10.1.1.   By Value

10.2.                 Market Share & Forecast

10.2.1.   By Product

10.2.2.   By Type of Biopsy

10.2.3.   By Application

10.2.4.   By End User

10.2.5.   By Country

10.3.                 South America: Country Analysis

10.3.1.   Brazil Cancer Biopsy Market Outlook

10.3.1.1.        Market Size & Forecast

10.3.1.1.1.             By Value

10.3.1.2.        Market Share & Forecast

10.3.1.2.1.             By Product

10.3.1.2.2.             By Type of Biopsy

10.3.1.2.3.             By Application

10.3.1.2.4.             By End User

10.3.2.   Argentina Cancer Biopsy Market Outlook

10.3.2.1.        Market Size & Forecast

10.3.2.1.1.             By Value

10.3.2.2.        Market Share & Forecast

10.3.2.2.1.             By Product

10.3.2.2.2.             By Type of Biopsy

10.3.2.2.3.             By Application

10.3.2.2.4.             By End User

10.3.3.   Colombia Cancer Biopsy Market Outlook

10.3.3.1.        Market Size & Forecast

10.3.3.1.1.             By Value

10.3.3.2.        Market Share & Forecast

10.3.3.2.1.             By Product

10.3.3.2.2.             By Type of Biopsy

10.3.3.2.3.             By Application

10.3.3.2.4.             By End User

11.  Middle East and Africa Cancer Biopsy Market Outlook

11.1.                 Market Size & Forecast

11.1.1.   By Value

11.2.                 Market Share & Forecast

11.2.1.   By Product

11.2.2.   By Type of Biopsy

11.2.3.   By Application

11.2.4.   By End User

11.2.5.   By Country

11.3.                 MEA: Country Analysis

11.3.1.   South Africa Cancer Biopsy Market Outlook

11.3.1.1.        Market Size & Forecast

11.3.1.1.1.             By Value

11.3.1.2.        Market Share & Forecast

11.3.1.2.1.             By Product

11.3.1.2.2.             By Type of Biopsy

11.3.1.2.3.             By Application

11.3.1.2.4.             By End User

11.3.2.   Saudi Arabia Cancer Biopsy Market Outlook

11.3.2.1.        Market Size & Forecast

11.3.2.1.1.             By Value

11.3.2.2.        Market Share & Forecast

11.3.2.2.1.             By Product

11.3.2.2.2.             By Type of Biopsy

11.3.2.2.3.             By Application

11.3.2.2.4.             By End User

11.3.3.   UAE Cancer Biopsy Market Outlook

11.3.3.1.        Market Size & Forecast

11.3.3.1.1.             By Value

11.3.3.2.        Market Share & Forecast

11.3.3.2.1.             By Product

11.3.3.2.2.             By Type of Biopsy

11.3.3.2.3.             By Application

11.3.3.2.4.             By End User

12.  Market Dynamics

12.1.                 Drivers

12.2.                 Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.                 Competition Outlook

14.2.                 Players Profiled

14.2.1.   Qiagen N.V.

14.2.2.   Illumina, Inc.

14.2.3.   ANGLE Plc

14.2.4.   Becton, Dickinson and Company

14.2.5.   Myriad Genetics Inc.

14.2.6.   Hologic, Inc.

14.2.7.   Biocept, Inc.

14.2.8.   Thermo Fisher Scientific, Inc.

14.2.9.   Danaher Corporation

14.2.10. F. Hoffmann-La Roche Ltd.

14.2.11. Lucence Diagnostics Pte. Ltd.

14.2.12. GRAIL, Inc.

14.2.13. Guardant Health Inc.

14.2.14. Exact Sciences Corporation

14.2.15. Freenome Holdings, Inc.

15.  Strategic Recommendations

16.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com